Skip to main content
This strategy yields potent inhibitors of A-beta aggregation and could lead to therapeutics for Alzheimer’s disease and other forms of neurodegeneration.

A New Approach Preventing Amyloid Aggregation May Result in Novel Therapeutics For Alzheimer’s Disease